Market revenue in 2021 | USD 1,563.6 million |
Market revenue in 2030 | USD 2,455.4 million |
Growth rate | 5.1% (CAGR from 2021 to 2030) |
Largest segment | Quadrivalent |
Fastest growing segment | Bivalent |
Historical data covered | 2018 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bivalent, Quadrivalent |
Key market players worldwide | Pfizer Inc, Sanofi SA, GSK PLC, Merck & Co Inc, Serum Institute of India Pvt. Ltd., Walvax Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to meningococcal vaccines market will help companies and investors design strategic landscapes.
Quadrivalent was the largest segment with a revenue share of 55.58% in 2021. Horizon Databook has segmented the North America meningococcal vaccines market based on bivalent, quadrivalent covering the revenue growth of each sub-segment from 2018 to 2030.
North America held the largest revenue share as it has highly regulated & well-developed healthcare infrastructure. Increasing access of vaccines through technology transfer and increasing local production of vaccines are anticipated to drive the market in the region.
Moreover, various campaigns and awareness programs are organized by charitable & nonprofit organizations such as National Meningitis Association (NMA), Meningitis Research Foundation of Canada, and Meningitis B Action Project, among others.
For instance, Meningitis Research Foundation of Canada conducts fund raising programs for research and raise awareness to support patients with meningitis, whereas the NMA educate healthcare professionals, public, & others about the disease and its prevention to protect families from the devastating effects of meningococcal disease.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America meningococcal vaccines market , including forecasts for subscribers. This continent databook contains high-level insights into North America meningococcal vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account